Palaty J, Burton R, Abbott F S
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
J Chromatogr B Biomed Appl. 1994 Dec 2;662(1):85-90. doi: 10.1016/0378-4347(94)00388-2.
A sensitive and efficient assay for gamma-aminobutyric acid (GABA) was applied to fresh mouse whole brain synaptosomes where the extracted GABA was analyzed as its di(tert.-butyl(dimethylsilyl)) derivative by gas chromatography-mass spectrometry (GC-MS) using GABA-d6 as an internal standard. Endogenous levels of 20.01 +/- 0.75 nmol GABA/mg protein were found. The method is characterized by a detection limit of about 10 fmol injected GABA derivative and coefficients of intra-day and inter-day variation of 0.95% and 7.7%, respectively. The rate of synaptosomal GABA synthesis was used to determine the activity of glutamate decarboxylase (GAD) as 314.9 +/- 9.0 nmol GABA/mg protein/h. Both GABA levels and GAD activity were significantly elevated by therapeutic doses of the antiepileptic drug valproic acid.
一种灵敏高效的γ-氨基丁酸(GABA)检测方法应用于新鲜的小鼠全脑突触体,其中提取的GABA以其二(叔丁基(二甲基硅基))衍生物形式,采用GABA-d6作为内标,通过气相色谱-质谱联用(GC-MS)进行分析。测得内源性GABA水平为20.01±0.75 nmol GABA/mg蛋白质。该方法的特点是注入的GABA衍生物检测限约为10 fmol,日内和日间变异系数分别为0.95%和7.7%。突触体GABA合成速率用于确定谷氨酸脱羧酶(GAD)的活性为314.9±9.0 nmol GABA/mg蛋白质/小时。抗癫痫药物丙戊酸的治疗剂量可显著提高GABA水平和GAD活性。